SBC Medical Group Holdings Incorporated (SBC) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Joining me on the call today are Yoshiyuki Aikawa, CEO, and Yuya Yoshida, CFO, COO, and AI Evangelist. I am Fukui, head of IR department, and I will be your moderator today. Transcription by CastingWords Thank you very much. First, around 10 minutes of presentation will be delivered using AI. Please rest assured since the content has been reviewed beforehand. Then there will be a message from Dr. Aikawa before we move on to the Q&A session. Please click Q&A icon at the bottom of the screen and type in and submit your questions. We will now start the presentation. Thank you for taking the time to join the second quarter 2026 conference call of SBC Medical Group Holdings Incorporated. I will now walk you through our results for the second quarter of 2026 and update on our business strategies and our capital and IR strategy. If I had to sum up this quarter in a single sentence, it is the quarter in which we completed the structural reforms we undertook in 2025 and SBC's growth entered a phase of re-acceleration. On the back of an expanding business base and more sophisticated support functions, including AI, we delivered profit growth that outpaced revenue growth. Let me begin with the clinic highlights. As of the end of June 2026, our number of locations reached 287, up 34 year on year. And the annual number of customer visits over the trailing 12 months was 6.92 million, up 10%. Year-to-date clinic revenue rose 11%, same clinic revenue was up 6%, and average spend per visit in the quarter increased 9%. With both customer volume and unit price rising together, our clinic business is showing renewed strength. Next are financial highlights. Second quarter revenue was $49 million, up 13% year on year. Adjusted EBITDA was $20 million, up 32%, and our adjusted EBITDA margin...